ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 743915 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 743915; 2) Community: the network communities that were significantly associated with the response to NSC 743915; 3) Molecule: the relationships between components within communities and NSC 743915; 4) MDR: the compounds that were significantly associated with the NSC 743915.

NSC Compound Enrichment Correlation
NSC 758662 Lovastatin [USAN] 0.0400159331976373 0.1331114
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0400159331976381 0.25463963
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.0400159331976381 0.042775522
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0400159331976381 0.013736396
NSC 218476 .beta.-D-Glucopyranose, 6-thio-, 6-(dimethylarsinite) 0.0400159331976381 0.14278552
NSC 228120 Benzofurazan, 4-[(3-methoxyphenyl)thio]-7-nitro-, 3-oxide 0.0400159331976381 -0.11752491
NSC 248040 Null 0.0400159331976381 0.074527645
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.0400159331976381 0.14410464
NSC 305767 2,4-Quinazolinediamine, 6-[(4-chlorophenyl)thio]- 0.0400159331976381 0.076147161
NSC 335753 HELIANGOLIDE 0.0400159331976381 0.1843746
Total:61  Current:51    [First] [Prev] [Next] [Last]